Learn More
Cayman Chemical ANTIBODY MB-07811 1mg

Supplier: Cayman Chemical 306701 MG
A liver-targeted prodrug of MB-07344; binds to TRα1 and TRβ1 (Kis = 12.5 and 14.6 µM, respectively); reduces plasma cholesterol levels (ED50 = 0.48 mg/kg) in a cholesterol-fed rat model; reduces hepatic steatosis, as well as plasma levels of cholesterol, in Zucker diabetic fatty rats in a model of NAFLD at 5 mg/kg per day; reverses hepatic steatosis, reducing total hepatic lipids without decreasing body weight, in a mouse model of diet-induced obesity at 10 mg/kg
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.